Claris Biotherapeutics, Inc. funding
Claris Biotherapeutics, Inc., a biotechnology company based in Half Moon Bay, CA, filed a Form D with the SEC on August 7, 2026 and reported $55.7M raised of a $121M offering.
Amount raised$55.7M
Offering size$121M
Filed with the SECAugust 7, 2026
First saleNovember 25, 2025
IndustryBiotechnology
SecuritiesEquity, Security to be acquired on exercise
LocationHalf Moon Bay, CA
FoundedMore than 5 years ago
Entity typeCorporation
Investors so far14
Minimum investment—
Revenue rangeDecline to Disclose
View the original Form D on SEC EDGAR ↗ · All rounds filed Aug 7
Other health care rounds in California
Alpfa Medical, Inc.$80.3M · Sep 28Other Health CareBigHat Biosciences, Inc.$75.1M · Oct 26BiotechnologyCaspian Therapeutics, Inc.$50M · Sep 23BiotechnologyEstuary Biotherapeutics, Inc.$40.7M · Oct 16BiotechnologyPFARADIGM Health, Inc.$31.1M · Sep 28Other Health CareTrellis Bioscience, Inc.$22.9M · Oct 21BiotechnologyAltay Therapeutics, Inc.$15.7M · Oct 2BiotechnologyAdela, Inc.$12M · Oct 19Biotechnology